Ardelyx to Participate at the Cowen 43rd Annual Health Care Conference
27 Februar 2023 - 2:15PM
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded
with a mission to discover, develop and commercialize innovative,
first-in-class medicines that meet significant unmet medical needs,
today announced that Mike Raab, president and chief executive
officer of Ardelyx, will participate in a GI/Microbiome panel
discussion at the Cowen 43rd Annual Health Care Conference on
Monday March 6, 2023 at 9:10 A.M. Eastern Time in Boston, MA.
To access the live webcast of the panel presentation please
visit the Events and Presentations page within the Ardelyx website
at https://ir.ardelyx.com/events-and-presentations. A replay of the
panel presentation will be available on the Ardelyx website for 30
days following the event.
About Ardelyx, Inc.
Ardelyx was founded with a mission to discover, develop and
commercialize innovative, first-in-class medicines that meet
significant unmet medical needs. Ardelyx’s first approved product,
IBSRELA® (tenapanor) is available in the United States and Canada.
Ardelyx is developing XPHOZAH® (tenapanor), a novel product
candidate for the control of serum phosphorus in adult patients
with chronic kidney disease (CKD) on dialysis, which has completed
three successful Phase 3 trials. Ardelyx has a Phase 2 potassium
lowering compound, RDX013, for the potential treatment of elevated
serum potassium, or hyperkalemia, a problem among certain patients
with kidney and/or heart disease and an early-stage program in
metabolic acidosis, a serious electrolyte disorder in patients with
CKD. Ardelyx has established agreements with Kyowa Kirin in Japan,
Fosun Pharma in China and Knight Therapeutics in Canada for the
development and commercialization of tenapanor in their respective
territories. For more information, please visit
https://ardelyx.com/ and connect with us on Twitter, LinkedIn and
Facebook.
Investor and Media Contacts:
Caitlin Lowieclowie@ardelyx.com
Kimia Keshtbodkkeshtbod@ardelyx.com
Ardelyx (NASDAQ:ARDX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Ardelyx (NASDAQ:ARDX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024